These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34558158)

  • 1. Head-to-head comparison of contemporary heart failure risk scores.
    Codina P; Lupón J; Borrellas A; Spitaleri G; Cediel G; Domingo M; Simpson J; Levy WC; Santiago-Vacas E; Zamora E; Buchaca D; Subirana I; Santesmases J; Diez-Quevedo C; Troya MI; Boldo M; Altmir S; Alonso N; González B; Rivas C; Nuñez J; McMurray J; Bayes-Genis A
    Eur J Heart Fail; 2021 Dec; 23(12):2035-2044. PubMed ID: 34558158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
    Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
    PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry.
    Codina P; Dobarro D; de Juan-Bagudá J; De Frutos F; Lupón J; Bayes-Genis A; Gonzalez-Costello J;
    ESC Heart Fail; 2023 Oct; 10(5):2875-2881. PubMed ID: 37991427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality Risk Prediction Dynamics After Heart Failure Treatment Optimization: Repeat Risk Assessment Using Online Risk Calculators.
    Codina P; Zamora E; Levy WC; Revuelta-López E; Borrellas A; Spitaleri G; Cediel G; Ruiz-Cueto M; Cañedo E; Santiago-Vacas E; Domingo M; Buchaca D; Subirana I; Santesmases J; de la Espriella R; Nuñez J; Lupón J; Bayes-Genis A
    Front Cardiovasc Med; 2022; 9():836451. PubMed ID: 35498033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble ST2, BCN-Bio-HF calculator and MAGGIC-HF score in long-term risk prediction after an urgent visit for heart failure.
    Pérez-Sanz TM; Gómez-Salvador I; Codina P; Calvo Antón B; de la Torre Carpente MM; Redondo Bermejo B; Tapia Ballesteros C
    Heart Vessels; 2024 Mar; 39(3):216-225. PubMed ID: 37872307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the heart failure risk scores in predicting 1 year mortality and short-term readmission of patients.
    Bo X; Zhang Y; Liu Y; Kharbuja N; Chen L
    ESC Heart Fail; 2023 Feb; 10(1):502-517. PubMed ID: 36325751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure.
    Cheng Y; Chai K; Zhu W; Wan Y; Liang Y; Du M; Li Y; Sun N; Yang J; Wang H
    Clin Interv Aging; 2021; 16():1669-1677. PubMed ID: 34556979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of multiparametric prediction scores in heart failure varies with the type of follow-up after discharge: a comparative analysis.
    Rodrigues T; Agostinho JR; Santos R; Cunha N; Silvério António P; Couto Pereira S; Brito J; Valente Silva B; Silva P; Rigueira J; Pinto FJ; Brito D;
    ESC Heart Fail; 2023 Aug; 10(4):2550-2558. PubMed ID: 37309653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure.
    Arzilli C; Aimo A; Vergaro G; Ripoli A; Senni M; Emdin M; Passino C
    Eur J Prev Cardiol; 2018 May; 25(8):889-895. PubMed ID: 29569494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Barcelona Bio-Heart Failure risk calculator may predict 1-year mortality in patients with advanced heart failure.
    Szczurek-Wasilewicz W; Skrzypek M; Karmański A; Jurkiewicz M; Gąsior M; Szyguła-Jurkiewicz B
    Pol Arch Intern Med; 2024 Aug; 134(7-8):. PubMed ID: 38804895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failure.
    McGranaghan P; Saxena A; Düngen HD; Rubens M; Appunni S; Salami J; Veledar E; Lacour P; Blaschke F; Obradovic D; Loncar G; Tahirovic E; Edelmann F; Pieske B; Trippel TD
    Sci Rep; 2021 Apr; 11(1):8164. PubMed ID: 33854188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator).
    Lupón J; de Antonio M; Vila J; Peñafiel J; Galán A; Zamora E; Urrutia A; Bayes-Genis A
    PLoS One; 2014; 9(1):e85466. PubMed ID: 24454874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides.
    Sawano M; Shiraishi Y; Kohsaka S; Nagai T; Goda A; Mizuno A; Sujino Y; Nagatomo Y; Kohno T; Anzai T; Fukuda K; Yoshikawa T
    ESC Heart Fail; 2018 Aug; 5(4):610-619. PubMed ID: 29520978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Prediction in Transition: MAGGIC Score Performance at Discharge and Incremental Utility of Natriuretic Peptides.
    Michaels A; Aurora L; Peterson E; Liu B; Pinto YM; Sabbah HN; Williams K; Lanfear DE
    J Card Fail; 2020 Jan; 26(1):52-60. PubMed ID: 31751788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Fonseca C; Chioncel O; Laroche C; Crespo-Leiro MG; Coats AJS; Mebazaa A; Piepoli MF; Tavazzi L; Maggioni AP;
    JACC Heart Fail; 2018 Jun; 6(6):452-462. PubMed ID: 29852929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction.
    Rich JD; Burns J; Freed BH; Maurer MS; Burkhoff D; Shah SJ
    J Am Heart Assoc; 2018 Oct; 7(20):e009594. PubMed ID: 30371285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Prognostic Risk Scores in Heart Failure Patients: Do Sex Differences Exist?
    Vishram-Nielsen JKK; Foroutan F; Ross HJ; Gustafsson F; Alba AC
    Can J Cardiol; 2020 Jan; 36(1):45-53. PubMed ID: 31874750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study.
    Alba AC; Buchan TA; Saha S; Fan S; Demers C; Poon S; Mak S; Al-Hesayen A; Toma M; Zieroth S; Anderson K; Porepa L; Chih S; Giannetti N; Rac V; Levy WC; Ross HJ; Guyatt GH
    Circ Heart Fail; 2023 Jul; 16(7):e010312. PubMed ID: 37337896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.